What is Stepan?
Founded in 1932 and headquartered in Northfield, Illinois, Stepan Company is a prominent manufacturer of basic and intermediate chemicals. Their diverse product portfolio includes surfactants, specialty products, germicidal and fabric softening quaternaries, phthalic anhydride (P.A.), and polyurethane polyols. Stepan also supplies special ingredients crucial for the food, supplement, and pharmaceutical markets, positioning itself as a key player in various industrial supply chains.
How much funding has Stepan raised?
Stepan has raised a total of $450M across 1 funding round:
Debt
$450M
Debt (2022): $450M with participation from BofA Securities and JPMorgan Chase
Key Investors in Stepan
BofA Securities
BofA Securities, Inc., formerly Bank of America Merrill Lynch, is a major multinational investment banking division of Bank of America, specializing in corporate finance and capital markets.
JPMorgan Chase
JPMorgan Chase & Co. is a global financial services firm offering investment banking, commercial banking, and asset management services worldwide.
What's next for Stepan?
The recent major strategic investment, alongside the substantial total funding, indicates Stepan Company is poised for continued expansion and innovation. This capital infusion is likely to fuel advancements in their specialty chemical offerings, potentially enhancing their market share in high-growth sectors such as pharmaceuticals and advanced materials. The company's long history and diversified product base suggest a robust strategy for navigating market dynamics and capitalizing on emerging opportunities.
See full Stepan company page
